Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials

Standard

Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials. / Zeidler, Claudia; Pereira, Manuel P; Augustin, Matthias; Spellman, Mary; Ständer, Sonja.

in: ACTA DERM-VENEREOL, Jahrgang 101, Nr. 2, adv00401, 17.02.2021.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{16d42f9f24fe46fbad9c9e5a108c2252,
title = "Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials",
abstract = "Chronic prurigo is a pruritic disease characterized by the development of pruriginous lesions due to scratching. The number of lesions is representative of the stage of the disease, while the presence of excoriations reflects the scratching activity. Aim of this study was to validate a new developed tool for the objective assessment of chronic prurigo. Investigator's Global Assessment scales for stage and activity were completed for 187 patients with chronic prurigo, who also reported patient-reported outcomes for itch intensity and quality of life. To assess the reliability and objectivity of the Investigator's Global Assessment, 5 independent raters completed the Investigator's Global Assessment scales for 8 patients twice. The scores increased with increased intensity of pruritus. The Investigator's Global Assessment stage scales correlated strongly with each other (Kendall's-tau-b 0.62) and moderately with the Investigator's Global Assessment activity scale (Kendall's-tau-b 0.47). Intra-rater test-retest reliability was excellent for all items, while the congruence among raters was very good for Investigator's Global Assessment - chronic prurigo activity (Kendall's W 0.84) and good for Investigator's Global Assessment stage scales (Kendall's W 0.747). Investigator's Global Assessment - chronic prurigo stage and activity are thus the best Investigator's Global Assessment instruments for use in assessing chronic prurigo.",
keywords = "Humans, Patient Reported Outcome Measures, Prurigo/diagnosis, Pruritus/diagnosis, Quality of Life, Reproducibility of Results",
author = "Claudia Zeidler and Pereira, {Manuel P} and Matthias Augustin and Mary Spellman and Sonja St{\"a}nder",
year = "2021",
month = feb,
day = "17",
doi = "10.2340/00015555-3701",
language = "English",
volume = "101",
journal = "ACTA DERM-VENEREOL",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "2",

}

RIS

TY - JOUR

T1 - Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials

AU - Zeidler, Claudia

AU - Pereira, Manuel P

AU - Augustin, Matthias

AU - Spellman, Mary

AU - Ständer, Sonja

PY - 2021/2/17

Y1 - 2021/2/17

N2 - Chronic prurigo is a pruritic disease characterized by the development of pruriginous lesions due to scratching. The number of lesions is representative of the stage of the disease, while the presence of excoriations reflects the scratching activity. Aim of this study was to validate a new developed tool for the objective assessment of chronic prurigo. Investigator's Global Assessment scales for stage and activity were completed for 187 patients with chronic prurigo, who also reported patient-reported outcomes for itch intensity and quality of life. To assess the reliability and objectivity of the Investigator's Global Assessment, 5 independent raters completed the Investigator's Global Assessment scales for 8 patients twice. The scores increased with increased intensity of pruritus. The Investigator's Global Assessment stage scales correlated strongly with each other (Kendall's-tau-b 0.62) and moderately with the Investigator's Global Assessment activity scale (Kendall's-tau-b 0.47). Intra-rater test-retest reliability was excellent for all items, while the congruence among raters was very good for Investigator's Global Assessment - chronic prurigo activity (Kendall's W 0.84) and good for Investigator's Global Assessment stage scales (Kendall's W 0.747). Investigator's Global Assessment - chronic prurigo stage and activity are thus the best Investigator's Global Assessment instruments for use in assessing chronic prurigo.

AB - Chronic prurigo is a pruritic disease characterized by the development of pruriginous lesions due to scratching. The number of lesions is representative of the stage of the disease, while the presence of excoriations reflects the scratching activity. Aim of this study was to validate a new developed tool for the objective assessment of chronic prurigo. Investigator's Global Assessment scales for stage and activity were completed for 187 patients with chronic prurigo, who also reported patient-reported outcomes for itch intensity and quality of life. To assess the reliability and objectivity of the Investigator's Global Assessment, 5 independent raters completed the Investigator's Global Assessment scales for 8 patients twice. The scores increased with increased intensity of pruritus. The Investigator's Global Assessment stage scales correlated strongly with each other (Kendall's-tau-b 0.62) and moderately with the Investigator's Global Assessment activity scale (Kendall's-tau-b 0.47). Intra-rater test-retest reliability was excellent for all items, while the congruence among raters was very good for Investigator's Global Assessment - chronic prurigo activity (Kendall's W 0.84) and good for Investigator's Global Assessment stage scales (Kendall's W 0.747). Investigator's Global Assessment - chronic prurigo stage and activity are thus the best Investigator's Global Assessment instruments for use in assessing chronic prurigo.

KW - Humans

KW - Patient Reported Outcome Measures

KW - Prurigo/diagnosis

KW - Pruritus/diagnosis

KW - Quality of Life

KW - Reproducibility of Results

U2 - 10.2340/00015555-3701

DO - 10.2340/00015555-3701

M3 - SCORING: Journal article

C2 - 33236125

VL - 101

JO - ACTA DERM-VENEREOL

JF - ACTA DERM-VENEREOL

SN - 0001-5555

IS - 2

M1 - adv00401

ER -